The improved rational designs have been widely employed to develop siRNA‐based therapies for CNS diseases.[208] For instance, Wang intravenously injected nanocomplex contained BACE‐1‐targeting siRNA to an AD mouse model. The gene discussed is BACE1; the disease is Alzheimer disease.